During early pregnancy, the endometrium undergoes pronounced hormone-dependent functional changes in preparation for embryo implantation. Local autocrineÀparacrine signaling at the fetalÀmaternal interface is crucial for the establishment of pregnancy. We previously reported that the transcription factor C/ EBPb, which is expressed at the implantation sites (ISs) in pregnant mice, acts as a key mediator of steroid hormone responsiveness in the endometrium. Mice lacking C/EBPb fail to support implantation due to defects in epithelial proliferation and stromal cell differentiation. In the current study, C/EBPb expression was dramatically stimulated in the endometrium of baboons (Papio anubis) during the window of uterine receptivity in response to a local infusion of chorionic gonadotropin, an embryonic signal. A robust induction of C/EBPb expression was also seen at the IS in the baboon and the human. Collectively, our results indicate that C/EBPb is a biomarker of endometrial receptivity and plays a conserved functional role during implantation in the primate.
INTRODUCTION
Implantation involves a complex series of signaling events between the developing embryo and the endometrium. [1] [2] [3] [4] In many species, including the rodents, it is well established that the endometrial tissue undergoes extensive proliferation, differentiation, and remodeling in response to the steroid hormones estrogen and progesterone. 5 The uterine luminal epithelium attains a functional receptive state, which makes it competent for blastocyst attachment. The underlying stromal cells undergo a hormonally induced transformation known as decidualization, which is essential for supporting the growth and survival of the implanted embryo. In primates, additional paracrine signals from the developing embryo produce further morphological and biochemical changes in the steroid-primed uterus to promote uterine receptivity and implantation. 6 Although the identities of the molecular pathways that control uterine receptivity and decidualization are not fully understood, it is clear that perturbations in these pathways cause uterine dysfunctions leading to early pregnancy loss and female infertility. Therefore, there is a critical need to identify molecules that would serve as useful biomarkers of the receptive state of human endometrium.
Recent gene targeting studies using transgenic mouse models revealed that a variety of factors, including transcription regulators, cytokines, morphogens, and growth factors, function downstream of steroid hormone signaling to control early phases of fetalÀmaternal interactions during implantation. [7] [8] [9] . We have previously identified C/EBPb, a CCAAT box-binding transcription factor, as a key steroid-regulated molecule involved in the proliferation and differentiation of uterine epithelial and stromal cells in the mouse. 10 In pregnant mice, uterine expression of C/EBPb is observed in the uterine luminal epithelium during the receptive phase. Thereafter, the C/ EBPb expression shifts to the decidualizing stromal cells surrounding the implanted embryo. The uteri of C/ EBPb-null mice are nonreceptive to embryo implantation and exhibit a complete lack of response to a deciduogenic stimulus, indicating a critical role of this transcription factor in regulating uterine receptivity and stromal differentiation program. 10, 11 A rational next step in our research is to evaluate C/ EBPb as a potential marker of uterine receptivity in the primate. Despite many similarities in the processes of implantation and placentation in rodents and primates, differences also exist between these species. For example, in humans and nonhuman primates, a limited differentiation of endometrial stroma occurs spontaneously during the secretory phase of the menstrual cycle. This stromal transformation, which is initiated in the absence of an embryo, is critical for uterine receptivity and becomes more wide spread with progressive phases of implantation during the first trimester of pregnancy. In contrast, in rodents, decidualization occurs in response to implanting embryos. 12 In humans, for ethical reasons, distinct stages of implantation and pregnancy are difficult to study due to the lack of available tissue. Thus, a nonhuman primate, such as the baboon (Papio anubis), is an important research model for basic and preclinical studies relevant to humans. The current study assesses C/EBPb as a marker of receptivity of baboon endometrium during normal and simulated pregnancy conditions. Our findings suggest that C/EBPb expression is intimately associated with attainment of uterine receptivity in the primates.
MATERIALS AND METHODS

Materials
Recombinant human chorionic gonadotropin (hCG) was obtained from Dr A. F. Parlow (National Hormone and Pituitary Program, Harbor-UCLA Medical center, Torrance, California) and from EMD Serono (Rockland, Massachusetts). Rabbit polyclonal antibody against C/ EBPb was obtained from Santa Cruz Biotechnology, Inc (Santa Cruz, California). Recombinant human interleukin 1b (IL-1b) and interleukin 1 (IL-1) receptor antagonist (IL-1Ra) were obtained from R&D systems (Minneapolis, Minnesota).
Tissue Collection
Endometrial tissues (n ¼ 3/stage) were obtained from normal cycling, and pregnant female baboons (P anubis) as described previously. 13 All experimental procedures were approved by the Animal Care Committee of the University of Illinois (Chicago, Illinois). Uteri from pregnant baboons (days 15-60 of pregnancy) were obtained by endometriectomy or hysterectomy. The stage of pregnancy was confirmed by ultrasound and by circulating levels of baboon Chorionic Gonadotropin (CG), estrogen, and progesterone, as described previously. 14, 15 After visualization of the site of attachment, the uterine tissue directly under or immediately adjacent to the implantation site (IS) was obtained.
For simulated pregnancy studies, normally cycling baboons were treated with hCG. Uterine tissues were obtained as described previously 13 from untreated or hCG-treated animals (n ¼ 3 for each group). Ovulation was detected in cycling female baboons by measuring peripheral serum levels of estradiol, beginning 7 days after the first day of menses. The day of the estradiol surge was designated day 1; the day of the ovulatory Luteinizing Hormone (LH) surge as day 0, and the day of ovulation as day 1. On day 5 postovulation (PO), an oviductal cannula was attached to an Alzet osmotic minipump (ALZA Corp, Mountain View, California), and recombinant hCG was infused at a rate of 1.25 IU/h for 5 days, as previously described. Endometrial tissues of hCG-treated animals were obtained on days 10 to 15 PO. In some experiments, IL-1b or IL-1Ra (12 ng/d) was infused together with hCG. The IL-1b or IL-1Ra infusion was begun on day 10 PO together with hCG and was continued for an additional 5 days. The experiment was terminated on day 15 PO (which corresponds to day 5 after implantation in pregnant baboons).
Human ISs were obtained at 8 and 9 weeks of gestation from curettage specimens at the time of elective terminations. The use of these archival tissues for research was approved by the Institutional Review Boards of the University of Illinois and John H. Stroger Jr Hospital of Cook County, Chicago, Illinois. Tissues were formalin fixed and paraffin embedded.
Immunohistochemistry
Uterine tissues were fixed in Bouin solution or 10% buffered formalin for 24 hours at room temperature, dehydrated in graded ethanol, cleared in xylene, and embedded in paraffin. Paraffin-embedded uterine sections, 4mm, were stained for C/EBPb as described previously. 10, 11 Intensity of immunostaining was measured using semiquantitative histologic scoring (HSCORE) system. At least 7 nonoverlapping fields of 40Â magnification for each time point were used for the quantitation. The equation HSCORE ¼ SPi(I þ 1), where I represents the staining intensity (values of 1, 2, or 3 signify weak, moderate, or strong staining, respectively) was used to calculate HSCORES.
RESULTS
Induction of C/EBPβ in the Receptive Baboon Endometrium
Previous studies have shown that in normally cycling baboon, endometrial receptivity is induced in the absence of an embryo following infusion of hCG into the uterine cavity of the female. 16 Administration of hCG, which mimics an embryonic signal, to steroid hormoneprimed baboon results in epithelial plaque (EP) formation due to hypertrophy of the surface epithelium (SE), stromal cell differentiation, and an increase in glandular secretory activity, which are early indicators of maternal response to pregnancy. We used this simulated pregnancy model (described in Materials and Methods) to examine the expression of C/EBPb in the baboon endometrium. As shown in Figure 1A , a low level of C/EBPb expression was observed in the endometrial tissue of untreated animals on days 11 PO or 14 PO (panels a and c). In contrast, a dramatic increase in C/EBPb expression was seen on day 11 PO or day 14 PO upon infusion of hCG into the uterine cavity of the cycling baboon starting day 5 PO (panels b and d). As shown in Figure 1A (panels b and d), greatly enhanced nuclear staining of C/EBPb was observed in the EP cells and the underlying stromal fibroblasts, indicating that the expression of this factor coincides with the receptive state of baboon endometrium.
Previous studies reported that IL-1b, a proinflammatory cytokine, plays a critical role in hCG-induced changes that are associated with the establishment of uterine receptivity. 13, 17 Treatment with IL-1Ra, an IL-1b receptor antagonist, prevented hCG-induced formation of EP, resulting in a nonreceptive uterus. We, therefore, examined the effects of the blockade of IL-1b signaling on hCG-induced C/EBPb expression in the simulated pregnancy model. As shown in Figure 1B , a low level of C/EBPb expression was detected on day 15 PO. However, marked enhancement in C/EBPb expression was observed on day 15 PO in the endometrial sections treated with a combination of hCG and IL-1b (Figure 1 B, panel b ). The staining of C/EBPb was localized in the epithelial cell clusters and the subepithelial stromal cells. Strikingly, C/EBPb expression was abolished when IL-1Ra was administered along with hCG into the uteri of cycling baboons (panel c). These results indicated that IL-1b signaling pathway plays a critical role in hCG-induced expression of C/EBPb in the receptive baboon endometrium. Our studies also revealed that agents that prevent the creation of a receptive uterus also blocked C/EBPb expression. The appearance of this transcription factor in the hormone-primed endometrium is thus potentially functionally linked with uterine receptivity.
Expression of C/EBPβ in Baboon Decidua at the IS
We next monitored the expression of C/EBPb in the baboon endometrium during normal pregnancy ( Figure 2 ). Attachment of the embryo to the uterine wall, leading to the establishment of pregnancy, constitutes the final phase of uterine receptivity. The prominent morphological features of this phase are glandular hypertrophy and differentiation of stromal cells into decidual cells. The expression of C/EBPb was observed in the predecidual stromal cells as early as days 10, 14, and 15 of pregnancy ( Figure 2A , panels a, b, and c, respectively). Quantification of C/EBPb immunopositive cells in the stroma showed a gradual increase from day 10 to day 15 of pregnancy ( Figure 2B ). With the progress of pregnancy, intense expression of C/EBPb was observed in the stromal cells surrounding the IS on day 21 ( Figure 2C , panels a and b), day 40 ( Figure 2C , panel c), and day 57 ( Figure 2C, panel d) . On closer examination, it was evident that the C/EBPb immunostaining in the maternal decidua on days 40, 57, and 60 is localized in the nucleus and it most likely represented the active form of this transcription factor ( Figure 2D ). Collectively, these results indicated that C/EBPb is expressed in the predecidual as well as decidual stromal cells at the baboon IS during early pregnancy, and its expression continues in these cells during mid pregnancy. These results are consistent with our previous description of a marked nuclear localization of C/EBPb protein in both proliferating and differentiating stromal cells surrounding the implanted embryos as the decidualization process progressed in pregnant mouse uterus. 10 
Expression of C/EBPβ in Baboon Placenta
During pregnancy in the baboon, in addition to C/EBPb expression in the decidua, a high level of this protein was observed in the placenta through gestation day 60 ( Figure 3 ). C/EBPb staining was prominent in the syncytiotrophoblast (ST, indicated by arrow in panels b, c, and d) of chorionic villi of the baboon placenta on days 40, 57, and 60 of pregnancy (panels a, b, and c, respectively). Remarkably, the villous cytotrophoblast (CT, indicated by arrow in panel d) of the baboon placenta was negative for C/EBPb immunostaining at all stages of gestation ( Figure 3 ). The strong placental expression of C/EBPb pointed to a possible role of this transcription factor during trophoblast differentiation and function. 
Expression of C/EBPβ in Decidua and Placenta at the IS in the Human
We have recently reported the expression of C/EBPb in human endometrium during the menstrual cycle. 18 A marked increase in nuclear C/EBPb immunostaining was observed in the glandular and stromal cells beginning on about cycle day 20, when the human endometrium attains the embryo-receptive status, and it continued for the remainder of the cycle. To further examine the biological significance of C/EBPb function during pregnancy, we examined its expression at ISs in archival human endometrial tissues. As shown in Figure 4A , a moderate level of C/EBPb expression was detected in the endometrial SE during the first trimester of pregnancy (indicated by arrow, panels a and b, 8 weeks, panel c, 9 weeks). However, intense nuclear expression of C/EBPb was observed in decidual stromal cells at the IS during this period (indicated as ''S'' in Figure 4A , panels b, and c). As shown in Figure 4B , there was no significant difference in stromal C/EBPb immunostaining between weeks 8 and 9 of pregnancy. No C/EBPb expression was observed in the endometrial glands in any of the samples studied. The expression of C/EBPb was also localized in the decidua (indicated as D in Figure 4C , panels b, c, and d) and villous ST in the human first-trimester placenta ( Figure 4C , indicated as ST in panels a and d). In contrast, the CT remained negative for C/EBPb immunostaining. The pattern of C/EBPb expression in the decidua (panels b, c, and d) and placenta (PL, panel d) at the human IS is remarkably similar to that observed in the pregnant baboon endometrium.
DISCUSSION
C/EBPb is a transcription factor that belongs to the C/EBP family of basic leucine-zipper proteins, which also includes C/EBPa and C/EBPd. 19 Our previous studies revealed a critical role of this factor in the regulation of murine uterine function during implantation. 10, 11 In the mouse, lack of C/ EBPb in the uterus leads to multiple functional abnormalities, including impaired epithelial cell proliferation in response to estrogen and a loss of decidual response to an artificial stimulus. 10 Embryo transfer experiments conducted in ovariectomized C/EBPb-null mice supplemented with estrogen and progesterone revealed that the mutant uterus is refractory to embryo attachment. 10 Because C/EBPb is a critical mediator of steroid hormone responsiveness in pregnant mouse uterus, it is important to understand its pattern of expression in human and nonhuman primates during pregnancy. The current study reports pronounced nuclear expression of C/EBPb in the decidua and placenta at the ISs of pregnant human and baboon. The documentation of expression of a key steroid-regulated factor, with established functional role in the mouse uterus, at the ISs of human and nonhuman primates represents an important first step in advancing translational research in uterine biology.
We have uncovered an important functional link between C/EBPb expression and the receptive status of baboon endometrium. Endometrial receptivity for embryo implantation in the baboon occurs in distinct phases. [20] [21] [22] [23] Phase I, regulated by the steroid hormones estrogen and progesterone, spans days 8 to 10 PO of the normal menstrual cycle. This phase is characterized by the presence of columnar epithelium and an increase in stromal cell proliferation. We noted that a low level of C/EBPb was expressed in the stromal cells at this phase of the cycle, presumably in response to estrogen and progesterone. Phase II of uterine receptivity is induced by signals from the blastocyst superimposed on the hormone-primed receptive endometrium. Morphologically phase II is remarkably distinct from phase I. During phase II, hypertrophic surface epithelial cells form EP, which is an early indicator of maternal response to pregnancy. Previous studies have shown that stage II of the receptive endometrium can be induced in the absence of an embryo by infusion of hCG into the uterine cavity of the cycling baboon. 16 Administration of hCG, which mimics an embryonic signal, to steroid hormone-primed baboon endometrium creates simulated pregnancy conditions and results in EP formation. Remarkably, we observed that hCG treatment leads to a robust stimulation of C/EBPb expression in the EP and in the subluminal stromal cells during simulated pregnancy. These results suggested an intimate connection between the expression of this transcription factor in endometrial cells and creation of the receptive state of the uterus. Most importantly, this functional link is conserved among species as varied as the rodents and primates.
Previous studies have shown that hCG-mediated morphological and functional transformation of the baboon endometrium, such as the formation of EP, is critically dependent on signaling by cytokines such as IL-1b. 23 Uterine infusion of the IL-1 receptor antagonist IL-1Ra, which prevents binding and activation of IL-1b signaling pathway, suppressed hCG-induced uterine receptivity in baboons. Interestingly, the IL-1Ra-mediated inhibition of uterine receptivity was associated with a concomitant loss of C/EBPb expression in the EP and in subluminal stromal cells. It is conceivable that steroid hormones, along with hCG, IL-1b, and presumably other embryonic factors, are critical for maximal expression and function of C/EBPb in the receptive baboon endometrium.
The final stage of uterine receptivity (Phase III) is initiated following embryo attachment and implantation. [20] [21] [22] This phase is marked by a significant increase in permeability of the subepithelial capillaries surrounding the blastocyst, along with glandular hypertrophy and initiation of stromal decidualization. Our study shows that the predecidual cells in the early pregnant baboon endometrium and the decidual cells near the spiral arteries in the mid-pregnancy maternal decidua express a high level of C/EBPb protein. This high expression level in decidual cells is maintained until day 60 of gestation.
Based on our previous studies in the murine model, where C/EBPb continues to be expressed in the stromal cells throughout the decidualization period, it is likely that this transcription factor is involved in the induction as well as maintenance of stromal differentiation program in the baboon decidua. 10 Interestingly, a previous study using primary cultures of human endometrial stromal cells suggested that C/ EBPb is a potential mediator of the 3 0 -5 0 -cyclic adenosine monophosphate (cAMP)-dependent endometrial stromal decidualization in the human. 24 In this study, the authors showed that the protein kinase A (PKA)-dependent activation of the decidual prolactin promoter, a major differentiation marker in human endometrial stromal cells, involves cooperative interaction of forkhead/ winged-helix transcription factor with C/EBPb. We recently analyzed the in vivo expression of C/EBPb in the human endometrium during the menstrual cycle. 18 Although the epithelial expression of C/EBPb did not change significantly during the cycle, an increased expression of C/EBPb was observed in the stromal cells during the mid-secretory phase of the cycle, which overlaps with the putative window of implantation. The study, however, did not address the C/EBPb expression profile in the human endometrium during pregnancy.
Our current study reveals prominent expression of C/EBPb at the IS during the first trimester of pregnancy. While the endometrial expression of this factor is mostly localized in the stromal cells, moderate expression is also observed in SE at 8 weeks of gestation. The pattern of C/ EBPb expression in the human IS resembles the widespread and intense expression of this transcription factor in decidual stromal cells surrounding the implanted embryo in pregnant mouse uterus. Although it is clear that the induction of C/EBPb in the mouse arises from the interplay of estrogen and progesterone within the uterine compartments, regulation of this factor in the human endometrium is not fully understood. Preliminary studies in our laboratory indicate that estrogen, progesterone, and cAMP are necessary for maximal expression of C/EBPb in human endometrial stromal cells (W Wang, PhD, RN Taylor, MD, PhD, IC Bagchi, PhD, and MK Bagchi, PhD, unpublished data, 2009 ).
Our study also shows C/EBPb expression in the baboon and human placenta. Baboon placenta at days 40 to 60 of gestation and first-trimester human placenta showed elevated C/EBPb expression in the ST cells of both free and anchoring villi. In contrast, CT cells were devoid of C/EBPb expression at all stages in both species. Although the precise role of C/EBPb in placental function is unclear, previous studies reported that it regulates the expression of critical placenta-specific genes during pregnancy. For example, the homeodomain gene, Distal-less 3, which plays an essential role in normal placental development, is regulated by C/EBPb in human placental cells. 25 Furthermore, the gene encoding human aromatase cytochrome P450, a critical enzyme involved in the conversion of androgens to estrogens, is also transcriptionally regulated by C/EBPb in human placental cells. 26 In summary, our studies document, for the first time, the expression of C/EBPb critical regulator of implantation in the mouse, at ISs of human and nonhuman primates. The results presented in this article are consistent with a conserved role of this key transcription factor in the regulation of uterine receptivity, stromal decidualization, and placental function during early pregnancy. These findings also support the hypothesis that C/EBPb expression in the endometrium and placenta is a prerequisite for successful embryo implantation in primates.
